(Q39028706)

8 September 2017

title

EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma (English)

1 reference

8 September 2017

Naohisa Futamura

1

1 reference

8 September 2017

Yoshihiro Nishida

2

1 reference

8 September 2017

Hiroshi Urakawa

3

1 reference

8 September 2017

Eiji Kozawa

4

1 reference

8 September 2017

Kunihiro Ikuta

5

1 reference

8 September 2017

Shunsuke Hamada

6

1 reference

8 September 2017

Naoki Ishiguro

7

1 reference

8 September 2017

publication date

31 January 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

5159-5165

1 reference

Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Risk stratification based on the clinical factors at diagnosis is closely related to the survival of localized osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Prognostic impact of extracellular matrix metalloprotease inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1668-8

Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions

21 January 2018

1 reference

12 December 2020

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1 reference

12 December 2020

Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience

1 reference

12 December 2020

Limb-saving surgery, survival, and prognostic factors for osteosarcoma: the Hungarian experience

1 reference

12 December 2020

Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: Correlation with tumor progression and patients’ prognosis

1 reference

12 December 2020

The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily

1 reference

12 December 2020

Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma

1 reference

12 December 2020

Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma

1 reference

12 December 2020

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol

1 reference

12 December 2020

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

12 December 2020

Matrix metalloproteinases and angiogenesis

1 reference

12 December 2020

Survival data for 648 patients with osteosarcoma treated at one institution

1 reference

12 December 2020

Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma

1 reference

12 December 2020

EMMPRIN-mediated MMP regulation in tumor and endothelial cells

1 reference

12 December 2020

Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to cisplatin in laryngeal carcinoma Hep2 cells

1 reference

12 December 2020

Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma

1 reference

12 December 2020

10.1007/S13277-014-1668-8

Identifiers

DOI

1 reference

8 September 2017

1 reference